Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels

Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels

Dettagli Bibliografici
Autori principali:	Hopewell, J, Clarke, R, Seedorf, U, Farrall, M, Hamsten, A, Collins, R, Watkins, H, Consortium, PROCARDIS
Natura:	Journal article
Pubblicazione:	2010

Documenti analoghi

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease
di: Hopewell, J, et al.
Pubblicazione: (2014)

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.
di: Hopewell, J, et al.
Pubblicazione: (2014)

Oxidized phospholipids, Lp(a) and coronary heart disease risk
di: Clarke, R, et al.
Pubblicazione: (2012)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk
di: Kyriakou, T, et al.
Pubblicazione: (2014)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk.
di: Kyriakou, T, et al.
Pubblicazione: (2014)

Independent relevance of renal function for coronary artery disease
di: Hopewell, J, et al.
Pubblicazione: (2010)

Plasma cytokines and risk of coronary heart disease in the PROCARDIS study
di: Clarke, R, et al.
Pubblicazione: (2018)

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
di: Clarke, R, et al.
Pubblicazione: (2009)

Impact of apolipoprotein(a) isoform size on lipoprotein(a) lowering in the HPS2-THRIVE study
di: Parish, S, et al.
Pubblicazione: (2018)

Genetic Variants in Lp(a) Lipoprotein and Coronary Disease REPLY
di: Farrall, M, et al.
Pubblicazione: (2010)

Independent Relevance of Cytokines for Risk of Coronary Heart Disease
di: Clarke, R, et al.
Pubblicazione: (2012)

Common Genetic Variants Associated With Higher Lp(a) Concentrations and Increased Risk of Coronary Heart Disease
di: Clarke, R, et al.
Pubblicazione: (2009)

ASSOCIATION STUDY OF CORONARY ARTERY DISEASE (CAD) USING HUMANCVD 50K CHIP
di: Goel, A, et al.
Pubblicazione: (2009)

LPA NULL MUTATION GENOTYPING AND QPCR ANALYSIS REFINE KRINGLE ISOFORM ANALYSIS OF LP(A) LEVELS
di: Kyriakou, T, et al.
Pubblicazione: (2014)

COMMON GENETIC VARIANTS ASSOCIATED WITH LOW Lp(a) KRINGLE-IV COPY NUMBER, HIGH Lp(a) CONCENTRATION, AND INCREASED RISK OF CORONARY HEART DISEASE
di: Seedorf, U, et al.
Pubblicazione: (2010)

Apolipoprotein proteomics for residual lipid-related risk in coronary heart disease
di: Clarke, R, et al.
Pubblicazione: (2023)

Plasma lipoproteins: apolipoprotein structure and function.
di: R W Mahley, et al.
Pubblicazione: (1984-12-01)

Lipoprotein (a) and apolipoprotein BD100 in coronary heart disease pathogenesis
di: K. I. Tebloev, et al.
Pubblicazione: (2005-10-01)

Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.
di: Farrer, M, et al.
Pubblicazione: (1994)

Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
di: Ruotolo, G, et al.
Pubblicazione: (1998)

Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study.
di: Hopewell, J, et al.
Pubblicazione: (2011)

Evidence from a family based study of gene association of lymphotoxin alpha with coronary artery disease (CAD)
di: Green, F, et al.
Pubblicazione: (2004)

Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol‐Lowering Therapy
di: Dick C. Chan, et al.
Pubblicazione: (2019-04-01)

Turkish Heart Study: lipids, lipoproteins, and apolipoproteins.
di: R W Mahley, et al.
Pubblicazione: (1995-04-01)

A functional polymorphism in the apolipoprotein B promoter that influences the level of plasma low density lipoprotein
di: Ferdinand M. van 't Hooft, et al.
Pubblicazione: (1999-09-01)

Influence of polyunsaturated fats on composition of plasma lipoproteins and apolipoproteins
di: G L Vega, et al.
Pubblicazione: (1982-08-01)

Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
di: Björkegren, J, et al.
Pubblicazione: (1998)

Rat plasma lipoproteins and apolipoproteins in experimental hypothyroidism.
di: L Dory, et al.
Pubblicazione: (1981-02-01)

Relationship between Apolipoprotein E Genotype and Lipoprotein Profile in Patients with Coronary Heart Disease
di: Yahui Lin, et al.
Pubblicazione: (2022-02-01)

Comparison of apolipoprotein B to cholesterol in low density lipoproteins of patients with coronary heart disease.
di: G L Vega, et al.
Pubblicazione: (1984-06-01)

The Impact of Genetic Variants Related to LDL-cholesterol on Risk of Ischemic Stroke and Coronary Heart Disease
di: Hopewell, J, et al.
Pubblicazione: (2012)

Apolipoproteins and the structural organization of plasma lipoproteins: human plasma high density lipoprotein-3.
di: C Edelstein, et al.
Pubblicazione: (1979-02-01)

Clinical and Prognostic Value of Non-Fasting Lipoproteins and Apolipoproteins in Chinese Patients with Coronary Heart Disease
di: Junfeng Zhang, et al.
Pubblicazione: (2023-11-01)

Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?
di: Waldomiro Carlos Manfroi, et al.
Pubblicazione: (1999-06-01)

Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese
di: Kuo-Liong Chien, et al.
Pubblicazione: (2007-11-01)

Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort
di: Anastasiya Matveyenko, et al.
Pubblicazione: (2023-03-01)

Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency
di: S Bijvoet, et al.
Pubblicazione: (1996-03-01)

Alterations in plasma lipoproteins and apolipoproteins in experimental allergic encephalomyelitis.
di: V G Shore, et al.
Pubblicazione: (1987-02-01)

Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE.
di: Karpe, F, et al.
Pubblicazione: (1994)

Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE.
di: F Karpe, et al.
Pubblicazione: (1994-07-01)